ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New DA-001 hair loss treatment heads to Large-Scale trial
Disease control Not yet recruitingThis study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated Jun 17, 2026 05:41 UTC
-
New hair loss drug combo enters human trials
Disease control Not yet recruitingThis early-stage study tests two forms of a hair loss drug (AD-303A topical and AD-3031 oral) in 30 men aged 19-55 with male pattern baldness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. The study will help decide the right dose f…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Moogene Medi Co., Ltd • Aim: Disease control
Last updated Jun 17, 2026 05:40 UTC
-
One-shot hair fix? new study pits nanofat against daily cream
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat tissue) can outperform either platelet-rich plasma (PRP) injections or daily topical minoxidil 5% for treating male and female pattern baldness. Sixty adults aged 18-50 with confirmed androgenetic alopecia will…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Can stem cell exosomes boost laser hair regrowth? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether adding a stem-cell-derived exosome solution to fractional laser therapy helps regrow hair better than laser alone. Thirty men with male pattern baldness will receive three laser sessions and be followed for six months. Researchers will measure changes in …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC
-
Amniotic fluid injection could be new hope for baldness
Disease control Not yet recruitingThis study tests whether an injection made from processed human amniotic fluid, called XVIE, is safe and may help regrow hair in adults with male or female pattern baldness. Thirty participants will receive either XVIE or a placebo injected into the scalp twice, 90 days apart, an…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Restore Biologics Holdings, Inc. dba Xtressé • Aim: Disease control
Last updated Jun 05, 2026 12:09 UTC
-
AI could soon diagnose hair loss with a simple photo
Diagnosis Not yet recruitingThis study aims to train artificial intelligence (AI) to diagnose male and female pattern hair loss and determine how severe it is. Researchers will use images from a handheld dermoscope along with patient age and sex to teach the AI. The goal is to see if AI can accurately tell …
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 16, 2026 12:50 UTC
-
New hair loss pill enters final testing phase
Symptom relief Not yet recruitingThis study tests an oral medication called N1087 (minoxidil) to see if it can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo pill daily for 24 weeks. The main goal is to measure change…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Jun 16, 2026 12:49 UTC